‘When investors understand the implications of using xeno free mediums and fycosylation homing technology which trebles the accuracy of payload delivery ... in combination with 3D bioreactors, you will realise that Cynata ,Athersys & Pluristem may have an uphill struggle commercialising their respective technologies .....if they survive the patent challenges !”
This conclusion says it all, thank you OP. “Stem Cells” were tested successfully by many companies, only MSB can take it to the commercial stage efficiently. Brilliant!
‘When investors understand the implications of using xeno free...
-
- There are more pages in this discussion • 194 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.03 |
Change
0.080(8.42%) |
Mkt cap ! $1.176B | |||
| Open | High | Low | Value | Volume |
| 95.5¢ | $1.03 | 95.0¢ | $43.38M | 42.28M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 72752 | $1.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.03 | 205100 | 2 |
View Market Depth
| Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |